1. Home
  2. OXM vs PRTC Comparison

OXM vs PRTC Comparison

Compare OXM & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Industries Inc.

OXM

Oxford Industries Inc.

HOLD

Current Price

$38.00

Market Cap

579.9M

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$17.46

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXM
PRTC
Founded
1942
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
579.9M
464.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OXM
PRTC
Price
$38.00
$17.46
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$44.80
N/A
AVG Volume (30 Days)
294.4K
3.9K
Earning Date
03-26-2026
08-28-2025
Dividend Yield
7.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$1,493,854,000.00
$6,391,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.68
N/A
P/E Ratio
N/A
$8.37
Revenue Growth
N/A
1265.60
52 Week Low
$30.57
$13.30
52 Week High
$75.89
$20.00

Technical Indicators

Market Signals
Indicator
OXM
PRTC
Relative Strength Index (RSI) 49.55 45.00
Support Level $35.89 $18.31
Resistance Level $41.60 $18.98
Average True Range (ATR) 1.92 0.54
MACD 0.04 -0.18
Stochastic Oscillator 42.88 5.75

Price Performance

Historical Comparison
OXM
PRTC

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: